Timothy L. Moore - Net Worth and Insider Trading
Timothy L. Moore Net Worth
The estimated net worth of Timothy L. Moore is at least $9 Million dollars as of 2025-03-22. Timothy L. Moore is the EVP, Technical Operations of Kite Pharma Inc and owns about 45,661 shares of Kite Pharma Inc (KITE) stock worth over $8 Million. Timothy L. Moore is the Chief Technical Officer of Allogene Therapeutics Inc and owns about 250,713 shares of Allogene Therapeutics Inc (ALLO) stock worth over $408,662. Timothy L. Moore is also the Director of Cerus Corp and owns about 7,911 shares of Cerus Corp (CERS) stock worth over $12,064. Details can be seen in Timothy L. Moore's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy L. Moore has not made any transactions after 2025-02-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Timothy L. Moore
Timothy L. Moore Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy L. Moore owns 5 companies in total, including Cerus Corp (CERS) , Kite Pharma Inc (KITE) , and BioLife Solutions Inc (BLFS) among others .
Click here to see the complete history of Timothy L. Moore’s form 4 insider trades.
Insider Ownership Summary of Timothy L. Moore
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CERS | Cerus Corp | 2020-02-11 | director |
KITE | Kite Pharma Inc | 2017-10-03 | EVP & Technical Operations |
BLFS | BioLife Solutions Inc | 2022-09-01 | director |
![]() | ![]() | 2022-09-06 | Chief Operating Officer |
![]() | ![]() | 2025-02-03 | Chief Technical Officer |
Timothy L. Moore Latest Holdings Summary
Timothy L. Moore currently owns a total of 3 stocks. Among these stocks, Timothy L. Moore owns 45,661 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $8 Million and a weighting of 95.12%. Timothy L. Moore owns 250,713 shares of Allogene Therapeutics Inc (ALLO) as of February 3, 2025, with a value of $408,662 and a weighting of 4.74%. Timothy L. Moore also owns 7,911 shares of Cerus Corp (CERS) as of February 11, 2020, with a value of $12,064 and a weighting of 0.14%.
Latest Holdings of Timothy L. Moore
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KITE | Kite Pharma Inc | 2017-09-25 | 45,661 | 179.79 | 8,209,391 |
ALLO | Allogene Therapeutics Inc | 2025-02-03 | 250,713 | 1.63 | 408,662 |
CERS | Cerus Corp | 2020-02-11 | 7,911 | 1.53 | 12,064 |
Holding Weightings of Timothy L. Moore
Timothy L. Moore Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy L. Moore has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 11,739 shares on September 25, 2017, which brought Timothy L. Moore around $1 Million.
According to the SEC Form 4 filings, Timothy L. Moore has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 14,746 shares on February 3, 2025, which brought Timothy L. Moore around $25,216.
According to the SEC Form 4 filings, Timothy L. Moore has made a total of 0 transactions in Cerus Corp (CERS) over the past 5 years. The most-recent trade in Cerus Corp is the acquisition of 3,614 shares on February 11, 2020, which cost Timothy L. Moore around $17,167.
Insider Trading History of Timothy L. Moore
- 1
Timothy L. Moore Trading Performance
GuruFocus tracks the stock performance after each of Timothy L. Moore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy L. Moore is 30.59%. GuruFocus also compares Timothy L. Moore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy L. Moore within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy L. Moore's insider trading performs compared to the benchmark.
Performance of Timothy L. Moore
Timothy L. Moore Ownership Network
Ownership Network List of Timothy L. Moore
Ownership Network Relation of Timothy L. Moore

Timothy L. Moore Owned Company Details
What does Cerus Corp do?
Who are the key executives at Cerus Corp?
Timothy L. Moore is the director of Cerus Corp. Other key executives at Cerus Corp include President & Cerus Europe William Mariner Greenman , Chief Commercial Officer Vivek K Jayaraman , and Chief Medical Officer Richard J Benjamin .
Cerus Corp (CERS) Insider Trades Summary
Over the past 18 months, Timothy L. Moore made no insider transaction in Cerus Corp (CERS). Other recent insider transactions involving Cerus Corp (CERS) include a net sale of 218,807 shares made by Richard J Benjamin , a net sale of 211,391 shares made by Chrystal Menard , and a net sale of 285,289 shares made by Kevin Dennis Green .
In summary, during the past 3 months, insiders sold 834,247 shares of Cerus Corp (CERS) in total and bought 0 shares, with a net sale of 834,247 shares. During the past 18 months, 1,362,188 shares of Cerus Corp (CERS) were sold and 38,725 shares were bought by its insiders, resulting in a net sale of 1,323,463 shares.
Cerus Corp (CERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cerus Corp Insider Transactions
Timothy L. Moore Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy L. Moore. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Timothy L. Moore's mailing address is: Santa Monica Ca 90404.